- Home
- LYEL vs EVM Comparison
LYEL vs EVM Comparison
Compare LYEL & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- EVM
- Stock Information
- Founded
- LYEL 2018
- EVM 2002
- Country
- LYEL United States
- EVM United States
- Employees
- LYEL N/A
- EVM N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- LYEL Health Care
- EVM Finance
- Exchange
- LYEL Nasdaq
- EVM Nasdaq
- Market Cap
- LYEL 207.7M
- EVM 230.9M
- IPO Year
- LYEL 2021
- EVM N/A
- Fundamental
- Price
- LYEL $0.43
- EVM $8.78
- Analyst Decision
- LYEL Sell
- EVM
- Analyst Count
- LYEL 2
- EVM 0
- Target Price
- LYEL $1.00
- EVM N/A
- AVG Volume (30 Days)
- LYEL 752.1K
- EVM 55.8K
- Earning Date
- LYEL 05-05-2025
- EVM 01-01-0001
- Dividend Yield
- LYEL N/A
- EVM 4.01%
- EPS Growth
- LYEL N/A
- EVM N/A
- EPS
- LYEL N/A
- EVM 0.20
- Revenue
- LYEL $61,000.00
- EVM N/A
- Revenue This Year
- LYEL N/A
- EVM N/A
- Revenue Next Year
- LYEL N/A
- EVM N/A
- P/E Ratio
- LYEL N/A
- EVM $47.61
- Revenue Growth
- LYEL N/A
- EVM N/A
- 52 Week Low
- LYEL $0.39
- EVM $7.67
- 52 Week High
- LYEL $2.88
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- LYEL 39.54
- EVM 35.58
- Support Level
- LYEL $0.43
- EVM $8.49
- Resistance Level
- LYEL $0.51
- EVM $8.86
- Average True Range (ATR)
- LYEL 0.05
- EVM 0.18
- MACD
- LYEL 0.00
- EVM -0.04
- Stochastic Oscillator
- LYEL 23.43
- EVM 25.22
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income and alternative strategies to institutional investors, both in the United States and internationally.